May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Functional consequences of a novel mutation in ELOVL4 causing macular dystrophy
Author Affiliations & Notes
  • G. Karan
    Department of Ophthalmology and Visual Science, Program in Human Molecular Biology and Genetics, University of Utah, Salt lake city, UT
  • A. Maugeri
    Department of Human Genetics, University Medical Center Nijmegen, Nijmegen, The Netherlands
  • Z. Yang
    Department of Ophthalmology and Visual Science, Program in Human Molecular Biology and Genetics, University of Utah, Salt lake city, UT
  • L. Jiang
    Department of Ophthalmology and Visual Science, Program in Human Molecular Biology and Genetics, University of Utah, Salt lake city, UT
  • X. Li
    Department of Ophthalmology and Visual Science, Program in Human Molecular Biology and Genetics, University of Utah, Salt lake city, UT
  • F. Cremers
    Department of Human Genetics, University Medical Center Nijmegen, Nijmegen, The Netherlands
  • K. Zhang
    Department of Ophthalmology and Visual Science, Program in Human Molecular Biology and Genetics, University of Utah, Salt lake city, UT
  • Footnotes
    Commercial Relationships  G. Karan, None; A. Maugeri, None; Z. Yang, None; L. Jiang, None; X. Li, None; F. Cremers, None; K. Zhang, None.
  • Footnotes
    Support  EY14438 , EY14448, Ronald McDonald House Charities and The Steinbach Fund
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1766. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. Karan, A. Maugeri, Z. Yang, L. Jiang, X. Li, F. Cremers, K. Zhang; Functional consequences of a novel mutation in ELOVL4 causing macular dystrophy . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1766.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: ELOVL4 belongs to fatty acid elongase (ELO) family of genes. Members of the ELOVL4 family share common structural features, including multiple putative membrane–spanning domains, a single histidine cluster motif and putative dilysine motifs thought to signal ER retention. A 5–bp deletion of human ELOVL4 causes autosomal dominant stargardt like macular dystrophy (STGD3). This deletion results in a frame–shift and loss of C–terminal 51 amino acids that include the dilysine ER targeting signal. The goals of this study were to identify novel mutation, and determine the subcellular localization and functional consequences of wild type and mutant ELOVL4 in the cultured cells. Methods: Mutation screening of ELOVL4 gene was conducted in a family with macular dystrophy. Both wild type and mutant ELOVL4 cDNAs were cloned in a pEGFPC1 expression vector. The resultant recombinant constructs express EGFP–ELOVL4 fusion proteins and were used for mammalian cell transfection study. Biochemical and microscopic analysis were performed to investigate expression and localization of fusion proteins. Results: A C817G mutation resulting in ELOVL 270 stop was identified in a Dutch family with autosomal dominant macular dystrophy. We expressed EGFP–ELOVL4 proteins in mammalian cultured cells. Wild type protein was localized in the ER compartment. In contrast, the truncated mutant protein (which has no ER retention signal) appeared to be mislocalized to other compartments within transfected cells. Cells expressing mutant ELOVL4 underwent apoptotic cell death. Conclusions: We have identified a novel mutation in ELOVL4 causing autosomal dominant macular dystrophy. Wild type ELOVL4 is localized to ER, as predicted from its primary sequence. Mutant ELOVL4 has a different localization and causes apoptotic death. The above results could be an explanation of the photoreceptor cell degeneration in patients with STGD3 .

Keywords: apoptosis/cell death • gene/expression 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×